News about "Sanofi"

Sanofi to Acquire Dren Bio Bispecific Myeloid Cell Engager for Deep B-Cell Depletion

DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.

Sanofi | 24/03/2025 | By Aishwarya

CORXEL Signs Agreement with Sanofi for Aficamten in Greater China Markets

Aficamten is an investigational, next-in-class selective small molecule cardiac myosin inhibitor discovered and developed globally by Cytokinetics.

Sanofi | 02/01/2025 | By Aishwarya

Sanofi Begins Shipping BEYFORTUS in US

Sanofi has started shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its vaccines for children program.

Sanofi | 18/09/2024 | By Aishwarya |  140

Sanofi Reveals Positive Results of Tolebrutinib in HERCULES Phase 3 Study

In the HERCULES study, nrSPMS was defined at baseline as having an SPMS diagnosis with an expanded disability status scale (EDSS) score between 3.0 and 6.5, no clinical relapses for the previous 24 months and documented evidence of disability accumulation in the previous 12 months.

Sanofi | 03/09/2024 | By Aishwarya |  178

Sanofi Starts Shipping US Influenza Vaccines for 2024-25

Sanofi has begun shipped its first influenza (flu) vaccines across the U.S. in preparation for the 2024–25 flu season.

Sanofi | 11/07/2024 | By Aishwarya |  480

Sanofi and Biovac to Manufacture Inactivated Polio Vaccines in Africa

Sanofi has signed local manufacturing partnership with Biovacto to produce inactivated polio vaccines (IPV) in Africa.

Sanofi | 27/06/2024 | By Aishwarya |  298

Sanofi Announces Complete Acquisition of Inhibrx

Sanofi has recently announced the complete acquisition of Inhibrx, Inc.

Sanofi | 31/05/2024 | By Aishwarya |  120

Sanofi, Formation Bio and OpenAI to Develop AI-Powered Software

Sanofi, Formation Bio and OpenAI have announced their collaboration to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.

Sanofi | 21/05/2024 | By Aishwarya |  210

Sartorius, Sanofi to Develop End-to-End Platform for Downstream Process Intensification

Sartorius has joined hands with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.

Sanofi | 14/05/2024 | By Aishwarya |  441

Fulcrum Signs License Deal with Sanofi for Development of Losmapimod in FSHD

Fulcrum Therapeutics has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod.

Sanofi | 14/05/2024 | By Aishwarya |  132